GlassScriptPhysician profile
Willard Nathan Applefeld
NPI 1992190045
$3,574.14
in general payments reported to CMS, 2019-2025
7 companies · $2,123 in 2025
The $2,123 reported for 2025 was more than what 87% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,026 · 2024: $425 · 2025: $2,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,139 · Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,139.13 |
| Food and Beverage | $1,435.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,908.12 | 2023-2025 | Triclip, Mitraclip |
| Medtronic, INC. | $177.57 | 2024-2025 | Micra, Invos |
| United Therapeutics Corporation | $164.61 | 2025 | Tyvaso, Remodulin, Orenitram |
| Abiomed | $130.89 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.09 | 2023 | Lifevest |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Ethicon US, LLC | $39.47 | 2024 | Stratafix, Monocryl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willard Applefeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.